Proposed Common share sales reported for ALL (NYSE: ALL)

Rhea-AI Filing Summary

ALL filing: reported proposed sales of Common stock via Form 144 with transactions dated 02/25/2026. The excerpt lists specific option-derived share amounts of 1,734, 12,879, and 19,373 tied to option grants dated 10/05/2022, 02/17/2022, and 02/16/2023, respectively.

Insights

Securities Compliance Counsel

Routine Form 144 sale notice tied to option exercises and grant dates.

The filing excerpt lists proposed dispositions of Common stock linked to option grants on 10/05/2022, 02/17/2022, and 02/16/2023

Timing and cash‑flow treatment are not detailed in the excerpt; subsequent compliance filings or broker confirmations will show settlement and proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	33986	7088485.06	259535842	02/25/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/25/2026	Option Granted 10/05/2022	Issuer			1734	02/25/2026	Cash
Common	02/25/2026	Option Granted 02/17/2022	Issuer			12879	02/25/2026	Cash
Common	02/25/2026	Option Granted 02/16/2023	Issuer			19373	02/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ALL report?

The Form 144 excerpt reports proposed sales of Common stock dated 02/25/2026. It lists option-derived share amounts of 1,734, 12,879, and 19,373 tied to specific option grant dates.

Which option grant dates are shown in the filing excerpt?

The excerpt shows option grant dates of 10/05/2022, 02/17/2022, and 02/16/2023. Each date is paired with a listed share amount in the table.

Who is the broker or intermediary listed in the Form 144 excerpt?

The excerpt names Fidelity Brokerage Services LLC with an address at 900 Salem Street, Smithfield, RI. That broker is shown in the securities table for the proposed transactions.

Do the numbers in the excerpt indicate total proceeds?

The excerpt includes numeric fields such as 7,088,485.06 and other counts but does not present an explicit labeled total proceeds calculation in the visible text. The filing shows proposed share amounts and related entries.

Are the listed share amounts exercises or unrestricted shares?

The table ties the listed amounts (1,734, 12,879, 19,373) to entries labeled 'Option Granted' with corresponding grant dates, indicating they relate to option awards rather than unrestricted open‑market holdings.